mu/kappa/delta opioid receptor agonists (Alchemia/University of Queensland)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemu/kappa/delta opioid receptor agonists (Alchemia/University of Queensland)
Drug Alias Nameopioid receptor agonists (Alchemia/University of Queensland)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionδ-opioid receptor agonistsKappa opioid receptor agonistsSodium channel protein type IX alpha subunit blockers +[4] 
TargetsSodium channel protein type IX alpha subunitMu opioid receptorKappa opioid receptor +[4] 
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New ZealandUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlchemia Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of QueenslandAstrazeneca PlcAlchemia Ltd
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A